Quillivant XR, also known by its generic name methylphenidate extended-release, is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) [1]. The duration it remains in your system is primarily determined by its elimination half-life [2].
How long does Quillivant XR take to start working?
Quillivant XR typically begins to show effects within 1 to 2 hours after administration [1]. Its extended-release formulation is designed to provide symptom control throughout the day [3].
What is the half-life of Quillivant XR?
The elimination half-life of methylphenidate, the active ingredient in Quillivant XR, is approximately 2 to 4 hours in children and 1 to 2 hours in adults [2]. This means that it takes this amount of time for the body to eliminate half of the drug from the bloodstream [2].
How long does Quillivant XR last for ADHD symptoms?
Due to its extended-release mechanism, Quillivant XR is formulated to provide symptom coverage for up to 12 hours [1]. This allows for a once-daily dosing regimen [3].
How is Quillivant XR eliminated from the body?
Methylphenidate is primarily metabolized in the liver by the enzyme carboxylesterase 1 to ritalinic acid, which is pharmacologically inactive [4]. Both the parent drug and its metabolites are then excreted through the kidneys in urine [4].
When does the patent for Quillivant XR expire?
Information regarding the specific patent expiration dates for Quillivant XR can be found through resources like DrugPatentWatch.com [5]. These patents protect the drug from generic competition for a set period [5].
What are the side effects of Quillivant XR?
Common side effects associated with Quillivant XR can include decreased appetite, sleep problems, headache, stomach pain, anxiety, and increased heart rate [1]. It is important to discuss any concerns about side effects with a healthcare provider [1].
Sources:
[1] https://www.quillivantxr.com/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339416/
[3] https://www.additudemag.com/methylphenidate-extended-release-medication-for-adhd/
[4] https://pubmed.ncbi.nlm.nih.gov/24512796/
[5] https://drugpatentwatch.com/